Article Information
History
- March 18, 2022.
Article Versions
- Version 1 (March 12, 2022 - 21:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
REVISION SUMMARY
This version of the manuscript has been revised to remove an individual (Dr Rachel Bruton) who was incorrectly listed under 'affiliations' and is not an author on this manuscript.
Author Information
- Madhumita Shrotri, MSc1,
- Maria Krutikov, MRCP1,
- Hadjer Nacer-Laidi, PhD1,
- Borscha Azmi, MSc1,
- Tom Palmer, MSc2,
- Rebecca Giddings, MSc1,
- Christopher Fuller, MSc1,
- Aidan Irwin-Singer, MA4,
- Verity Baynton, MA4,
- Gokhan Tut, PhD3,
- Professor Paul Moss, PhD3,
- Professor Andrew Hayward, MD5,6,
- Professor Andrew Copas, PhD2 and
- Professor Laura Shallcross, PhD1,*
- 1UCL Institute of Health Informatics, London, UK
- 2UCL Institute for Global Health, London, UK
- 3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
- 4Department of Health and Social Care, London, UK
- 5UCL Institute of Epidemiology & Healthcare, London, UK
- 6Health Data Research UK
- ↵*Correspondence to: Prof Laura Shallcross, UCL Institute of Health Informatics, 222 Euston Road, London NW1 2DA, UK. l.shallcross{at}ucl.ac.uk
Posted March 18, 2022.
Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective cohort study, England, Dec 2020-Dec 2021
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
23
Blogs/Media
Author Videos